← All trials
NCT02241278
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2001
- Primary completion
- Jun 1, 2002
- Completion date
- Jun 1, 2002
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Arquitecto MarcideLead sponsor
- Complexo Hospitalario Universitario de A CoruñaCollaborator
- Hospital Arquitecto MarcideOverall official - principal investigator
- Complexo Hospitalario Universitario de A CoruñaOverall official - principal investigator
- Complexo Hospitalario Universitario de A CoruñaReponsible party - principal investigator
- Hospital Arquitecto MarcideStudy chair
- Complexo Hospitalario Universitario de A CoruñaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.